Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.19)
# 3,431
Out of 4,829 analysts
321
Total ratings
32.27%
Success rate
-18.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Maintains: Buy | $115 → $100 | $15.42 | +548.51% | 12 | May 8, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $75 → $40 | $36.27 | +10.28% | 12 | May 7, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $45 → $50 | $32.30 | +54.82% | 2 | May 1, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $5.03 | +178.33% | 12 | Apr 30, 2025 | |
| EDIT Editas Medicine | Initiates: Buy | $3 | $1.45 | +106.90% | 1 | Apr 28, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $72 | $65.87 | +9.31% | 35 | Apr 25, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $31.78 | +136.00% | 37 | Apr 16, 2025 | |
| LYEL Lyell Immunopharma | Reiterates: Neutral | $1 | $0.40 | +150.00% | 12 | Apr 16, 2025 | |
| VERV Verve Therapeutics | Maintains: Buy | $15 → $25 | $4.23 | +491.02% | 6 | Apr 14, 2025 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $40 | $9.91 | +303.84% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.29 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $2.69 | +755.02% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $2.11 | +89.57% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.51 | +363.58% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $1.21 | +147.93% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.54 | +272.44% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.73 | +1,132.88% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $10.10 | +197.03% | 19 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $50 | $14.73 | +239.44% | 14 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.27 | +184.63% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.93 | - | 8 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $13.23 | +731.44% | 14 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $8.12 | +269.46% | 1 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 | $23.96 | +83.64% | 13 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $35.62 | +82.48% | 2 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $9.54 | +371.70% | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.19 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $1.73 | +35,260,015.61% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $6.90 | - | 4 | Jun 2, 2023 |
Korro Bio
May 8, 2025
Maintains: Buy
Price Target: $115 → $100
Current: $15.42
Upside: +548.51%
Sarepta Therapeutics
May 7, 2025
Maintains: Neutral
Price Target: $75 → $40
Current: $36.27
Upside: +10.28%
Ionis Pharmaceuticals
May 1, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $32.30
Upside: +54.82%
Alumis
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $5.03
Upside: +178.33%
Editas Medicine
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $1.45
Upside: +106.90%
Halozyme Therapeutics
Apr 25, 2025
Reiterates: Buy
Price Target: $72
Current: $65.87
Upside: +9.31%
Legend Biotech
Apr 16, 2025
Reiterates: Buy
Price Target: $75
Current: $31.78
Upside: +136.00%
Lyell Immunopharma
Apr 16, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.40
Upside: +150.00%
Verve Therapeutics
Apr 14, 2025
Maintains: Buy
Price Target: $15 → $25
Current: $4.23
Upside: +491.02%
Cartesian Therapeutics
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $9.91
Upside: +303.84%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.29
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $23
Current: $2.69
Upside: +755.02%
Apr 3, 2025
Maintains: Neutral
Price Target: $6 → $4
Current: $2.11
Upside: +89.57%
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.51
Upside: +363.58%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $1.21
Upside: +147.93%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.54
Upside: +272.44%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.73
Upside: +1,132.88%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $10.10
Upside: +197.03%
Mar 25, 2025
Maintains: Buy
Price Target: $55 → $50
Current: $14.73
Upside: +239.44%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.27
Upside: +184.63%
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.93
Upside: -
Mar 5, 2025
Reiterates: Buy
Price Target: $110
Current: $13.23
Upside: +731.44%
Mar 5, 2025
Initiates: Buy
Price Target: $30
Current: $8.12
Upside: +269.46%
Feb 25, 2025
Reiterates: Buy
Price Target: $44
Current: $23.96
Upside: +83.64%
Feb 13, 2025
Reiterates: Buy
Price Target: $65
Current: $35.62
Upside: +82.48%
Feb 7, 2025
Reiterates: Buy
Price Target: $45
Current: $9.54
Upside: +371.70%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.19
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $1.73
Upside: +35,260,015.61%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $6.90
Upside: -